News Release

<< Back

Sunesis to Present at Upcoming Investor Conferences

02/28/14

SOUTH SAN FRANCISCO, Calif., Feb. 28, 2014 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer and President of Sunesis, will present at two upcoming investor conferences;

  • Cowen & Company 34th Annual Health Care Conference
    Tuesday, March 4th at 10:40 AM Eastern Time
    The Boston Marriott Copley Place, Boston
     
  • 26th Annual Roth Conference
    Tuesday, March 11th at 10:00 AM Pacific Time
    The Ritz Carlton, Dana Point, CA

A live webcast of the presentations will be available on the Sunesis website at http://ir.sunesis.com. A replay of the webcast will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks.

About Sunesis Pharmaceuticals

Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, vosaroxin, in multiple indications to improve the lives of people with cancer.

For additional information on Sunesis, please visit http://www.sunesis.com.

CONTACT: Investor and Media Inquiries:
         David PittsArgot Partners
         212-600-1902

         Eric Bjerkholt
         Sunesis Pharmaceuticals Inc.
         650-266-3717

         Eliza SchleifsteinArgot Partners
         917-763-8106
         eliza@argotpartners.com

Sunesis Pharmaceuticals, Inc. Logo

Sunesis Pharmaceuticals, Inc.